Who Profits from Prohibition?

01 Follow the Money

Every policy has beneficiaries. The question that Irish drug policy never answers — because no one in power wants to ask it — is this: who benefits from prohibition?

The standard defence of cannabis prohibition is public health. The claim is that criminalising cannabis protects Irish citizens from harm. But prohibition does not eliminate the cannabis market. It has never eliminated the cannabis market. Not in Ireland, not anywhere in the world, not once in over fifty years of trying.

What prohibition does is transfer the market from regulated, taxed, quality-controlled channels into the hands of criminal organisations. It does not remove supply. It privatises it — to the most violent bidder.

To understand why prohibition persists despite decades of failure, you have to stop asking whether it works and start asking who it works for. The answer is a network of industries and institutions whose revenue depends, directly or indirectly, on cannabis remaining illegal.

Follow the money. It leads to five distinct beneficiaries: the alcohol industry, the private treatment sector, the pharmaceutical industry, the criminal justice system, and the political class that serves them.

02 The Alcohol Industry

No industry has more to lose from cannabis legalisation than the drinks industry. And no industry lobbies harder against it.

In Ireland, the alcohol sector is dominated by a small number of powerful players: Diageo (Guinness, Smithwick’s, Baileys), Heineken Ireland (which operates the former Beamish & Crawford brewery), C&C Group (Bulmers, Tennent’s), and a sprawling network of distributors, publicans, and off-licence chains. Their interests are represented by Drinks Ireland, the drinks sector division of IBEC — Ireland’s most powerful business lobby group.^[2]

Why would the alcohol industry care about cannabis? Because legal cannabis is a direct market substitute. People who use cannabis drink less alcohol. This is not speculation. It is measured, repeated, and documented.

The Irish alcohol market is worth approximately €7.6 billion annually.^[4] A 12% reduction would represent nearly €1 billion in lost revenue. For an industry built on volume — on the daily pint, the weekend session, the office party — that is an existential threat.

The Lobbying Machine

Drinks Ireland and its member companies maintain one of the most effective lobbying operations in the state. They have consistently opposed public health measures on alcohol — minimum unit pricing, advertising restrictions, cancer warning labels — and they have done so while funding research, sponsoring events, and cultivating political relationships.^[5]

The industry’s opposition to cannabis legalisation is rarely stated openly. It does not need to be. The lobbying infrastructure that protects alcohol’s privileged legal status also ensures that cannabis remains criminalised. When politicians speak of “protecting public health” by maintaining cannabis prohibition, they are, knowingly or not, protecting alcohol industry revenue.

Consider the irony: alcohol kills approximately 1,000 people in Ireland every year.^[6] Cannabis has killed none. The product that is legal, promoted, and protected is the one doing the damage. The product that is criminalised is the one that would reduce that damage — by giving people a safer alternative.

03 The Private Treatment Industry

Ireland has a growing private addiction treatment sector. Residential rehabilitation clinics charge between €10,000 and €20,000 or more for a single treatment episode.^[7] Some charge considerably more. Many of these clinics accept referrals for cannabis “addiction” — a condition whose clinical significance is debated, given that cannabis has a dependency rate of approximately 9%, compared to 32% for tobacco and 15% for alcohol.^[8]

Criminalisation creates a pipeline of clients for these clinics. The mechanism is straightforward: a person is caught with cannabis. They are charged. At court, their solicitor advises them to present evidence of “engagement with treatment” to secure a more lenient outcome. The person enrols in a treatment programme — often at their own expense — not because they need treatment, but because the criminal justice system demands it.

This is a circular economy of criminalisation. Prohibition creates the “problem” (criminal cannabis users), which creates the “demand” (court-mandated treatment), which creates the “evidence” (treatment statistics showing cannabis as a problem drug), which is used to justify continued prohibition. The treatment industry benefits at every step.

Decriminalisation would break this cycle. If cannabis possession were not a criminal offence, there would be no court appearances, no solicitor advice to “seek treatment,” and no pipeline of mandated referrals. The private treatment industry has a direct financial interest in ensuring that does not happen.

None of this is to suggest that problematic cannabis use does not exist. It does, and people who struggle with it deserve support. But conflating recreational use with clinical dependency — and using the criminal justice system as a referral mechanism — is not healthcare. It is a business model.

04 The Pharmaceutical Industry

In 2019, Epidiolex (cannabidiol) was approved for use in Ireland for the treatment of severe epilepsy. It costs approximately €10,000–€15,000 per year per patient.^[9] Sativex, a cannabis-based mouth spray for multiple sclerosis spasticity, costs approximately €500 per month.^[10] Both are patented pharmaceutical products manufactured by GW Pharmaceuticals (now owned by Jazz Pharmaceuticals, an Irish-domiciled company).

Here is the critical point: the active compounds in these medications — THC and CBD — are the same compounds found in the cannabis plant. The difference is that pharmaceutical companies can patent specific formulations, extraction processes, and delivery mechanisms. They cannot patent the plant itself.

If cannabis were legal and patients could grow their own or purchase it from regulated dispensaries at a fraction of the pharmaceutical cost, the market for patented cannabinoid medications would collapse. A patient paying €12,000 a year for Epidiolex could instead purchase whole-plant cannabis extract for a fraction of that price — with the same or similar therapeutic effect.

Ireland’s Medical Cannabis Access Programme (MCAP), launched in 2019 after years of delay, remains extremely restrictive. As of 2025, only a handful of patients have been able to access cannabis through the programme.^[11] The programme was designed to be narrow. It was designed not to work at scale. And the pharmaceutical industry benefits from that failure, because every patient who cannot access affordable plant-based cannabis is a potential customer for patented alternatives.

05 The Criminal Justice Industry

Cannabis prohibition is expensive to enforce. It is also a reliable source of activity, funding, and justification for a significant portion of Ireland’s criminal justice apparatus.

Consider the cost chain for a single cannabis possession prosecution:

Multiply that by the thousands of cannabis possession cases processed each year. The total cost to the Irish exchequer runs into the tens of millions — to prosecute people for possessing a substance that has never killed anyone.

These are not wasted resources in the eyes of the system. They are justified resources. Every cannabis arrest is a recorded detection. Every prosecution is a case processed. Every conviction is a statistic that demonstrates the criminal justice system is “working.” Gardaí earn overtime attending court for possession cases. Solicitors earn fees. Courts stay busy. Probation officers have caseloads. The system feeds itself.

In 2019, the Garda Commissioner drew attention to the strain that drug prosecutions place on policing resources.^[13] Despite this, there has been no political will to decriminalise possession — because the criminal justice system, as an institution, benefits from the volume. Fewer cannabis prosecutions means fewer detections, fewer court hours, fewer overtime claims, and a harder conversation about what Gardaí should actually be doing with their time.

06 The Political Donation Trail

The relationship between the alcohol industry and Irish politics is not a conspiracy. It is a matter of public record — disclosed in lobbying returns, political donations, and the career movements of former politicians.

The Standards in Public Office Commission (SIPO) records show that drinks industry entities and associated individuals have been consistent donors to Irish political parties.^[14] While individual donation amounts often fall below the public disclosure threshold of €1,500 (previously €5,078), the aggregate flow of money, hospitality, and access is substantial.

The Revolving Door

The movement of personnel between politics and the alcohol industry follows a well-established pattern across democratic states, and Ireland is no exception:

• Industry advisory roles: Former politicians and senior civil servants regularly take up consultancy or board positions with drinks companies and industry bodies after leaving public service
• Event sponsorship: Political party conferences, constituency events, and Oireachtas functions regularly feature alcohol industry sponsorship and hospitality
• Lobbying access: Drinks Ireland and its member companies are among the most active entities on the Lobbying Register, with regular meetings with Ministers and senior officials^[15]

This is not about corruption in the tabloid sense. It is about structural influence. The drinks industry does not need to bribe politicians. It needs only to be present — at the table, at the conference, on the register — to ensure that its interests are considered in every policy discussion. Cannabis legalisation never reaches the table because the people sitting at the table have a financial interest in keeping it off.

Meanwhile, cannabis users have no lobby group, no industry body, no political donors, and no representation. The power imbalance is total.

07 Who Loses

Every beneficiary of prohibition has a corresponding victim. While the alcohol industry protects its market share, while pharma protects its patents, while the justice system protects its caseload, real people pay the price.

Young People with Criminal Records

A cannabis possession conviction in Ireland creates a criminal record. That record affects employment, travel (particularly to the United States, Canada, and Australia), insurance, and housing applications. For a young person caught with a small amount of cannabis, the punishment — a permanent stain on their record — is vastly disproportionate to the offence.^[16]

The Spent Convictions legislation in Ireland is narrower than in most comparable jurisdictions. A cannabis conviction can follow a person for years, limiting their life chances long after the offence is forgotten by everyone except the system.

Communities Living with Criminal Markets

Prohibition does not remove cannabis from communities. It ensures that cannabis is supplied by criminal gangs rather than regulated businesses. The consequences are felt most acutely in disadvantaged communities: intimidation, violence, anti-social behaviour, and the recruitment of young people into drug distribution networks. Legalisation would not eliminate all of these problems, but it would remove the primary revenue source that funds them.

Farmers Who Could Grow Hemp

Industrial hemp — a variety of cannabis with negligible THC content — is one of the most versatile crops on earth. It can be used for textiles, construction materials, bioplastics, animal feed, and soil remediation. Ireland’s climate is well-suited to hemp cultivation. Yet restrictive licensing, stigma, and the association with cannabis prohibition have kept the Irish hemp industry marginal.^[17] Irish farmers are losing a potential revenue stream because politicians cannot distinguish between hemp and heroin.

Patients Who Need Medical Cannabis

Thousands of Irish patients with conditions including chronic pain, epilepsy, multiple sclerosis, and chemotherapy-related nausea could benefit from medical cannabis. The MCAP is functionally inaccessible to most of them. Many are forced to source cannabis illegally, at personal legal risk, or to travel abroad for treatment. Their suffering is the collateral damage of a policy designed to protect commercial interests, not public health.^[11]

The Exchequer

08 The Prohibition Industrial Complex

In the United States, the phrase “prison-industrial complex” describes the network of private prisons, contractors, and political interests that profit from mass incarceration. Ireland does not have private prisons, but it has something functionally similar: a prohibition industrial complex — a network of industries, institutions, and political actors whose revenue, relevance, or power depends on drug prohibition continuing.

Prohibition is not a policy failure. It is working exactly as designed — for the people who profit from it. The cannabis market exists whether it is legal or not. The only question is who controls it: criminal gangs or the state. Who collects the revenue: organised crime or the exchequer. Who sets the quality standards: nobody, or a regulator. Who checks the age of the buyer: no one, or a licensed retailer.

Every year that Ireland maintains cannabis prohibition, the state makes a choice: to forgo hundreds of millions in tax revenue, to criminalise thousands of its own citizens for a victimless offence, to cede a billion-euro market to organised crime, and to protect the commercial interests of the alcohol and pharmaceutical industries at the expense of public health, individual liberty, and fiscal common sense.

That is not drug policy. It is economic protectionism — for the wrong people.

The beneficiaries of prohibition will never call for its end. The political class will not lead. Change will come, as it always does in Ireland, when the public demands it — and when enough people understand who is profiting from the status quo.

Now you know.